January 28, 2015 12:11 PM ET


Company Overview of Convergence Pharmaceuticals Limited

Executive Profile

Brenda Reynolds

Chief Operating Officer, Convergence Pharmaceuticals Limited
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships


Mrs. Brenda Reynolds serves as the Chief Operations Officer of Convergence Pharmaceuticals Limited. Mrs. Reynolds serves as Managing Director of PowderMed Ltd. She serves as an Independent Consultant to other Biotech companies. She co-founded Powdermed Ltd., in May 2004 and served as its Chief Operations Officer from May 2004 to December 2006. She served as Head of Pre-clinical and Clinical Development at Immune Targeting Systems (ITS) Limited. She served as Vice President ...

Corporate Headquarters

Maia Building
Cambridge, Cambridgeshire CB22 3AT

United Kingdom

Phone: 44 1223 755 501
Fax: 44 1223 497 114

Board Members Memberships

Non Executive Director
Co-Founder, Chief Operating Officer and Director


Unknown/Other Education
University of Surrey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Convergence Pharmaceuticals Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.